{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:18:39Z","timestamp":1785525519710,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00f4pitaux de Paris","doi-asserted-by":"publisher","award":["CRC 2022"],"award-info":[{"award-number":["CRC 2022"]}],"id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022854","name":"European Cystic Fibrosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jcf.2025.01.004","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T07:54:30Z","timestamp":1737446070000},"page":"606-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Short-term modification of breathprint by Elexacaftor\/Tezacaftor\/Ivacaftor in a paediatric cohort"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4514-7095","authenticated-orcid":false,"given":"Emmanuelle","family":"Bardin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Hunzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Lamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Roquencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Tabache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1887-3702","authenticated-orcid":false,"given":"Laurence Le","family":"Clainche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Remus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8274-7180","authenticated-orcid":false,"given":"Charlotte","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Devillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao","family":"Nguyen-Khoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Chedevergne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Pontoizeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8729-6948","authenticated-orcid":false,"given":"Mairead","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5747-4432","authenticated-orcid":false,"given":"Stanislas","family":"Grassin Delyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5537-9482","authenticated-orcid":false,"given":"Isabelle","family":"Sermet-Gaudelus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jcf.2025.01.004_bib0001","doi-asserted-by":"crossref","first-page":"1809\u201119","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for cystic fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcf.2025.01.004_bib0002","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41467-023-36244-2","article-title":"Future therapies for cystic fibrosis","volume":"14","author":"Allen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2025.01.004_bib0003","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202210-1938LE","article-title":"Moving the dial on airway inflammation in response to Trikafta\u00ae in adolescents with cystic fibrosis","author":"Lepissier","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2025.01.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02153-2022","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis","volume":"62","author":"Schaupp","year":"2023","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.jcf.2025.01.004_bib0005","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/cells11071243","article-title":"CFTR modulator therapies: potential impact on airway infections in cystic fibrosis","volume":"11","author":"Saluzzo","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.jcf.2025.01.004_bib0006","doi-asserted-by":"crossref","first-page":"00731\u20112020","DOI":"10.1183\/23120541.00731-2020","article-title":"Lumacaftor\/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients","volume":"7","author":"Neerincx","year":"2021","journal-title":"ERJ Open Res"},{"issue":"6","key":"10.1016\/j.jcf.2025.01.004_bib0007","doi-asserted-by":"crossref","first-page":"996\u20111005","DOI":"10.1016\/j.jcf.2021.11.003","article-title":"A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung","volume":"21","author":"Sosinski","year":"2022","journal-title":"J Cystic Fibrosis"},{"issue":"1","key":"10.1016\/j.jcf.2025.01.004_bib0008","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12890-022-01903-5","article-title":"Lung clearance index to characterize clinical phenotypes of children and adolescents with cystic fibrosis","volume":"22","author":"Gambazza","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"5","key":"10.1016\/j.jcf.2025.01.004_bib0009","doi-asserted-by":"crossref","first-page":"514\u201121","DOI":"10.1136\/thoraxjnl-2020-215667","article-title":"Breathomics for the Clinician: the use of volatile organic compounds in respiratory diseases","volume":"76","author":"Ibrahim","year":"2021","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jcf.2025.01.004_bib0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1465-9921-13-117","article-title":"Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review","volume":"13","author":"van de Kant","year":"2012","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.jcf.2025.01.004_bib0011","first-page":"1352\u201163","article-title":"Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review","volume":"89","author":"RA","year":"2021","journal-title":"Pediatr Res"},{"issue":"10","key":"10.1016\/j.jcf.2025.01.004_bib0012","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/metabo12100980","article-title":"Identification of exhaled metabolites in children with cystic fibrosis","volume":"12","author":"Weber","year":"2022","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.jcf.2025.01.004_bib0013","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/ac522f","article-title":"Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study","volume":"16","author":"Woollam","year":"2022","journal-title":"J Breath Res"},{"issue":"5","key":"10.1016\/j.jcf.2025.01.004_bib0014","doi-asserted-by":"crossref","first-page":"929\u201136","DOI":"10.1183\/09031936.06.00085105","article-title":"Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis","volume":"27","author":"Barker","year":"2006","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2025.01.004_bib0015","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/abda55","article-title":"Exhaled volatile organic compounds detect pulmonary exacerbations early in children with cystic fibrosis: results of a 1 year observational pilot study","volume":"15","author":"van Horck","year":"2021","journal-title":"J Breath Res"},{"issue":"9","key":"10.1016\/j.jcf.2025.01.004_bib0016","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/biom14091189","article-title":"Identification of exhaled metabolites correlated with respiratory function and clinical features in adult patients with cystic fibrosis by real-time proton mass spectrometry","volume":"14","author":"Mustafina","year":"2024","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.jcf.2025.01.004_bib0017","doi-asserted-by":"crossref","first-page":"888\u201193","DOI":"10.1016\/j.jcf.2023.02.010","article-title":"Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis","volume":"22","author":"Licht","year":"2023","journal-title":"J Cystic Fibrosis"},{"issue":"1","key":"10.1016\/j.jcf.2025.01.004_bib0018","doi-asserted-by":"crossref","first-page":"e28\u201134","DOI":"10.1016\/j.jcf.2021.04.015","article-title":"Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients","volume":"21","author":"Kos","year":"2022","journal-title":"J Cystic Fibrosis"},{"issue":"2","key":"10.1016\/j.jcf.2025.01.004_bib0019","doi-asserted-by":"crossref","first-page":"118\u201125","DOI":"10.1002\/ppul.22876","article-title":"Interpretative consequences of adopting the Global Lungs 2012 reference equations for spirometry for children and adolescents","volume":"49","author":"Quanjer","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"22","key":"10.1016\/j.jcf.2025.01.004_bib0020","doi-asserted-by":"crossref","first-page":"4929\u201139","DOI":"10.1007\/s00216-024-05421-7","article-title":"Combination of real-time and hyphenated mass spectrometry for improved characterisation of exhaled breath biomarkers in clinical research","volume":"416","author":"Lamy","year":"2024","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"10.1016\/j.jcf.2025.01.004_bib0021","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41598-017-19120-0","article-title":"Missing value imputation approach for mass spectrometry-based metabolomics data","volume":"8","author":"Wei","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2025.01.004_bib0022","first-page":"gkae253","article-title":"MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcf.2025.01.004_bib0023","doi-asserted-by":"crossref","first-page":"1\u201148","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"issue":"2","key":"10.1016\/j.jcf.2025.01.004_bib0024","first-page":"79\u201183","article-title":"How to control confounding effects by statistical analysis","volume":"5","author":"Pourhoseingholi","year":"2012","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"3","key":"10.1016\/j.jcf.2025.01.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/abf1d0","article-title":"A literature survey of all volatiles from healthy human breath and bodily fluids: the human volatilome","volume":"15","author":"Drabi\u0144ska","year":"2021","journal-title":"J Breath Res"},{"issue":"5","key":"10.1016\/j.jcf.2025.01.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003311","article-title":"Volatile metabolites of pathogens: a systematic review","volume":"9","author":"Bos","year":"2013","journal-title":"PLoS Pathog"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2025.01.004_bib0027","article-title":"RIFM fragrance ingredient safety assessment, 2-butanone, CAS Registry Number 78-93-3","volume":"134","author":"Api","year":"2019","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"10.1016\/j.jcf.2025.01.004_bib0028","doi-asserted-by":"crossref","first-page":"392\u20119","DOI":"10.1165\/rcmb.2023-0349OC","article-title":"Breath markers of oxidative stress in children with severe viral lower respiratory tract infection","volume":"70","author":"Lilien","year":"2024","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.jcf.2025.01.004_bib0029","doi-asserted-by":"crossref","first-page":"243\u20119","DOI":"10.1067\/mlc.2000.108943","article-title":"Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress","volume":"136","author":"Phillips","year":"2000","journal-title":"J Lab Clin Med"},{"issue":"5","key":"10.1016\/j.jcf.2025.01.004_bib0030","doi-asserted-by":"crossref","first-page":"986\u20111000","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and Inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"10.1016\/j.jcf.2025.01.004_bib0031","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174500","article-title":"Arteriovenous metabolomics in pigs reveals CFTR regulation of metabolism in multiple organs","volume":"134","author":"Bae","year":"2024","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jcf.2025.01.004_bib0032","doi-asserted-by":"crossref","first-page":"339\u201155","DOI":"10.1159\/000225373","article-title":"Inert gas washout: theoretical background and clinical utility in respiratory disease","volume":"78","author":"Robinson","year":"2009","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.jcf.2025.01.004_bib0033","doi-asserted-by":"crossref","first-page":"1282\u201192","DOI":"10.1002\/ppul.25849","article-title":"Relationship between lung function and exhaled volatile organic compounds in healthy infants","volume":"57","author":"Sola-Mart\u00ednez","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.jcf.2025.01.004_bib0034","doi-asserted-by":"crossref","first-page":"e75274","DOI":"10.1371\/journal.pone.0075274","article-title":"Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry","volume":"8","author":"Phillips","year":"2013","journal-title":"PLoS One"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325000049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325000049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:08:48Z","timestamp":1762553328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325000049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1569199325000049"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.01.004","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term modification of breathprint by Elexacaftor\/Tezacaftor\/Ivacaftor in a paediatric cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}